Rockwell Medical (RMTI) Competitors $1.10 +0.01 (+0.92%) Closing price 04:00 PM EasternExtended Trading$1.12 +0.01 (+1.36%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RMTI vs. RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, and RMDShould you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), and ResMed (RMD). These companies are all part of the "health care equipment" industry. Rockwell Medical vs. Its Competitors ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed Rockwell Medical (NASDAQ:RMTI) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations. Which has stronger valuation & earnings, RMTI or RSLS? Rockwell Medical has higher revenue and earnings than ReShape Lifesciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRockwell Medical$101.49M0.37-$480KN/AN/AReShape Lifesciences$8.01M0.95-$7.13M-$193.23-0.02 Is RMTI or RSLS more profitable? Rockwell Medical has a net margin of -0.27% compared to ReShape Lifesciences' net margin of -48.26%. Rockwell Medical's return on equity of -0.90% beat ReShape Lifesciences' return on equity.Company Net Margins Return on Equity Return on Assets Rockwell Medical-0.27% -0.90% -0.47% ReShape Lifesciences -48.26%-251.90%-59.49% Does the media favor RMTI or RSLS? In the previous week, Rockwell Medical had 1 more articles in the media than ReShape Lifesciences. MarketBeat recorded 1 mentions for Rockwell Medical and 0 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 1.87 beat Rockwell Medical's score of 0.94 indicating that ReShape Lifesciences is being referred to more favorably in the news media. Company Overall Sentiment Rockwell Medical Positive ReShape Lifesciences Very Positive Do analysts rate RMTI or RSLS? Rockwell Medical currently has a consensus price target of $4.00, suggesting a potential upside of 263.64%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts clearly believe Rockwell Medical is more favorable than ReShape Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33ReShape Lifesciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders hold more shares of RMTI or RSLS? 23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are held by institutional investors. 3.6% of Rockwell Medical shares are held by company insiders. Comparatively, 0.0% of ReShape Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, RMTI or RSLS? Rockwell Medical has a beta of 1.57, meaning that its stock price is 57% more volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. SummaryRockwell Medical beats ReShape Lifesciences on 13 of the 15 factors compared between the two stocks. Get Rockwell Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RMTI vs. The Competition Export to ExcelMetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.25M$10.25B$5.54B$9.41BDividend YieldN/A2.06%3.75%4.03%P/E RatioN/A16.5828.0119.82Price / Sales0.3730.02433.8198.96Price / Cash8.6222.3936.1658.27Price / Book1.093.578.125.65Net Income-$480K$235.43M$3.25B$257.91M7 Day Performance-2.65%-1.67%0.97%2.09%1 Month Performance17.02%2.91%7.36%11.13%1 Year Performance-42.11%-16.44%31.31%18.40% Rockwell Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RMTIRockwell Medical3.9035 of 5 stars$1.10+0.9%$4.00+263.6%-46.2%$37.25M$101.49M0.00300News CoverageRSLSReShape LifesciencesN/A$2.38+0.4%N/A-99.2%$5.69M$8.01M-0.0150ABTAbbott Laboratories4.988 of 5 stars$133.62-0.6%$142.61+6.7%+15.3%$232.48B$41.95B17.33114,000Trending NewsEarnings ReportEx-DividendAnalyst ForecastISRGIntuitive Surgical4.7015 of 5 stars$534.71-1.8%$588.95+10.1%+21.1%$191.65B$8.35B78.4015,638Positive NewsUpcoming EarningsAnalyst RevisionBSXBoston Scientific4.6219 of 5 stars$103.75-0.5%$116.09+11.9%+35.1%$153.49B$16.75B75.7353,000Trending NewsUpcoming EarningsSYKStryker4.7787 of 5 stars$392.26-0.8%$427.30+8.9%+16.3%$149.72B$22.60B53.0153,000Positive NewsMDTMedtronic4.6379 of 5 stars$87.73-0.7%$97.87+11.6%+10.2%$112.52B$33.54B24.2395,000Positive NewsAnalyst ForecastAnalyst RevisionBDXBecton, Dickinson and Company4.7555 of 5 stars$172.92-1.8%$219.22+26.8%-22.8%$49.56B$20.18B33.0074,000Analyst RevisionEWEdwards Lifesciences4.3727 of 5 stars$76.64-0.2%$80.20+4.6%-12.7%$44.96B$5.44B10.9515,800Positive NewsUpcoming EarningsAnalyst ForecastIDXXIDEXX Laboratories3.6718 of 5 stars$545.56-0.3%$558.11+2.3%+4.5%$43.87B$3.90B50.4211,000Positive NewsAnalyst ForecastAnalyst RevisionRMDResMed4.2677 of 5 stars$256.16-0.3%$259.33+1.2%+24.5%$37.56B$4.69B28.759,980Positive NewsAnalyst UpgradeAnalyst Revision Related Companies and Tools Related Companies ReShape Lifesciences Alternatives Abbott Laboratories Alternatives Intuitive Surgical Alternatives Boston Scientific Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RMTI) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.